Acorda: Q2 Earnings Snapshot

Published on 5 Aug 2021 on Olean Times Herald

ARDSLEY, N.Y. (AP) — Acorda Therapeutics Inc. (ACOR) on Thursday reported a loss of $22.9 million in its second quarter.

Read the rest of the article

Start tracking your investments with Statfolio

(Bloomberg) -- The junkiest corporate debt is becoming increasingly hazardous for investors amid ...

Bloomberg via Yahoo Finance 6 Apr 2024

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday...

Investing.com 3 Apr 2024

JHVEPhoto Acorda Therapeutics (NASDAQ:ACOR) on Wednesday announced that Nasdaq notified the compa...

Seeking Alpha 3 Apr 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.00%

Investing.com 2 Apr 2024

Acorda Therapeutics , Inc. (NASDAQ: ACOR ), a biotechnology company focused on developing therapi...

Investing.com 2 Apr 2024

Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Investing.com 2 Apr 2024

Acorda Therapeutics plunges 59% after filing for Chapter 11 bankruptcy, citing debts of $266.2M....

Seeking Alpha 1 Apr 2024

Acorda Therapeutics, Inc. (NASDAQ:ACOR) shareholders are no doubt pleased to see that the share p...

Simply Wall St. via Yahoo Finance 18 Dec 2023

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript November 13, 2023 Operat...

Insider Monkey via Yahoo Finance 14 Nov 2023

Acorda Therapeutics Inc (NASDAQ:ACOR) experienced a daily loss of 11.31% and a three-month gain o...

GuruFocus.com via Yahoo Finance 28 Aug 2023